✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Cytokinetics Inc

Common Name
Cytokinetics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
498
Ticker
CYTK
Exchange
NASDAQ/NGS
Description
Cytokinetics, Incorporated is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative muscle activators and inhibitors. Its primary mission is to ad...

Cytokinetics's Financial Statements Preview

Below are the financial statements of Cytokinetics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenues
License and milestone revenues
15a
3.5a
1a
Collaboration revenues
3.47a
4.03a
6.59a
Realization of revenue participation right purchase agreement
0a
0a
87a
Total revenues
18.47a
7.53a
94.59a
Operating expenses
Research and development
-339.41a
-330.12a
-240.81a
General and administrative
-215.31a
-173.61a
-177.98a
Total operating expenses
-554.72a
-503.74a
-418.79a
Operating loss
-536.25a
-496.21a
-324.2a
Interest expense
-37.7a
-28.31a
-19.41a
Loss on extinguishment of debt
0a
0a
-24.94a
Non-cash interest expense on liabilities related to revenue participation right purchase agreements
-48.81a
-29.36a
-31.74a
Interest and other income, net
51.53a
27.63a
11.34a
Change in fair value of derivative liabilities
1.3a
0a
0a
Change in fair value of liabilities related to RPI transactions
-19.6a
0a
0a
Net loss
-589.53a
-526.24a
-388.96a
Limited Data Preview
You are viewing a limited preview of Cytokinetics’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Cytokinetics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cytokinetics’s data sources below and access millions more through our Disclosure Search.

a. Cytokinetics's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?